Hepatitis Monthly

Published by: Kowsar

Analysis of Antigenic and Conformational Changes in Hepatitis B Surface Antigen (HBsAg) Identified in Iranian Patients with Chronic Hepatitis B

Vahdat Poortahmasebi 1 , 2 , Mansour Poorebrahim 3 , Azam Ghaziasadi 1 , Mohammad Foad Abazari 4 , Sayed-Hamidreza Mozhgani 2 , Maryam Nouri Aleagha 4 , Forouzan Shahbazi 4 and Seyed Moayed Alavian 1 , 5 , *
Authors Information
1 Baqiyatallah Research Center for Gastroenterology and Liver Diseases, Baqiyatallah University of Medical Sciences, Tehran, IR Iran
2 Hepatitis B Molecular Laboratory, Department of Virology, School of Public Health, Tehran University of Medical Sciences, Tehran, IR Iran
3 Department of Medical Biotechnology, School of Advanced Technologies in Medicine, Tehran University of Medical Sciences, Tehran, IR Iran
4 Department of Genetics, Islamic Azad University, Tehran Medical Branch, Tehran, IR Iran
5 Middle East Liver Diseases (MELD) Center, Tehran, IR Iran
Article information
  • Hepatitis Monthly: September 2017, 17 (9); e57882
  • Published Online: September 3, 2017
  • Article Type: Research Article
  • Received: July 29, 2017
  • Revised: July 29, 2017
  • Accepted: August 28, 2017
  • DOI: 10.5812/hepatmon.57882

To Cite: Poortahmasebi V, Poorebrahim M, Ghaziasadi A, Abazari M F, Mozhgani S, et al. Analysis of Antigenic and Conformational Changes in Hepatitis B Surface Antigen (HBsAg) Identified in Iranian Patients with Chronic Hepatitis B, Hepat Mon. 2017 ; 17(9):e57882. doi: 10.5812/hepatmon.57882.

Copyright © 2017, Hepatitis Monthly. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
1. Background
2. Objectives
3. Methods
4. Results
5. Discussion
  • 1. Lavanchy D. Hepatitis B virus epidemiology, disease burden, treatment, and current and emerging prevention and control measures. J Viral Hepat. 2004; 11(2): 97-107[DOI][PubMed]
  • 2. European Association for the Study of the Liver. Electronic address EEE, European Association for the Study of the L. EASL 2017 Clinical Practice Guidelines on the management of hepatitis B virus infection. J Hepatol. 2017; 67(2): 370-98[DOI][PubMed]
  • 3. Stirk HJ, Thornton JM, Howard CR. A topological model for hepatitis B surface antigen. Intervirology. 1992; 33(3): 148-58[DOI][PubMed]
  • 4. Tiollais P, Pourcel C, Dejean A. The hepatitis B virus. Nature. 1985; 317(6037): 489-95[DOI][PubMed]
  • 5. Purdy MA. Hepatitis B virus S gene escape mutants. Asian J Transfus Sci. 2007; 1(2): 62-70[DOI][PubMed]
  • 6. Raimondo G, Allain JP, Brunetto MR, Buendia MA, Chen DS, Colombo M, et al. Statements from the Taormina expert meeting on occult hepatitis B virus infection. J Hepatol. 2008; 49(4): 652-7[DOI][PubMed]
  • 7. Alavian SM, Carman WF, Jazayeri SM. HBsAg variants: diagnostic-escape and diagnostic dilemma. J Clin Virol. 2013; 57(3): 201-8[DOI][PubMed]
  • 8. Norouzi M, Ghorashi S, Abedi F, Nejatizadeh A, Ataei B, Malekzadeh R, et al. Identification of Hepatitis B Virus Surface Antigen (HBsAg) Genotypes and Variations in Chronic Carriers from Isfahan Province, Iran. Iran J Public Health. 2012; 41(3): 104-11[PubMed]
  • 9. Ie SI, Thedja MD, Roni M, Muljono DH. Prediction of conformational changes by single mutation in the hepatitis B virus surface antigen (HBsAg) identified in HBsAg-negative blood donors. Virol J. 2010; 7: 326[DOI][PubMed]
  • 10. Carman WF, Zanetti AR, Karayiannis P, Waters J, Manzillo G, Tanzi E, et al. Vaccine-induced escape mutant of hepatitis B virus. Lancet. 1990; 336(8711): 325-9[DOI][PubMed]
  • 11. Khedive A, Norouzi M, Ramezani F, Karimzadeh H, Alavian SM, Malekzadeh R, et al. Hepatitis B virus surface protein mutations clustered mainly in CTL immune epitopes in chronic carriers: results of an Iranian nationwide study. J Viral Hepat. 2013; 20(7): 494-501[DOI][PubMed]
  • 12. Zhang Y. I-TASSER server for protein 3D structure prediction. BMC Bioinformatics. 2008; 9: 40[DOI][PubMed]
  • 13. Yang J, Zhang Y. Protein Structure and Function Prediction Using I-TASSER. Curr Protoc Bioinformatics. 2015; 52: 5 8 1-15[DOI][PubMed]
  • 14. Dindoost P, Jazayeri SM, Karimzadeh H, Saberfar E, Miri SM, Alavian SM. HBsAg variants: Common escape issues. Jundishapur J Microbiol. 2012; 5(4): 521-7[DOI]
  • 15. Zhang Q, Wang P, Kim Y, Haste-Andersen P, Beaver J, Bourne PE, et al. Immune epitope database analysis resource (IEDB-AR). Nucleic Acids Res. 2008; 36-8[DOI][PubMed]
  • 16. Carman WF. The clinical significance of surface antigen variants of hepatitis B virus. J Viral Hepat. 1997; 4 Suppl 1: 11-20[DOI][PubMed]
  • 17. Waters JA, Kennedy M, Voet P, Hauser P, Petre J, Carman W, et al. Loss of the common "A" determinant of hepatitis B surface antigen by a vaccine-induced escape mutant. J Clin Invest. 1992; 90(6): 2543-7[DOI][PubMed]
  • 18. Wu C, Deng W, Deng L, Cao L, Qin B, Li S, et al. Amino acid substitutions at positions 122 and 145 of hepatitis B virus surface antigen (HBsAg) determine the antigenicity and immunogenicity of HBsAg and influence in vivo HBsAg clearance. J Virol. 2012; 86(8): 4658-69[DOI][PubMed]
  • 19. Ponsel D, Bruss V. Mapping of amino acid side chains on the surface of hepatitis B virus capsids required for envelopment and virion formation. J Virol. 2003; 77(1): 416-22[DOI][PubMed]
  • 20. Gomez-Gutierrez J, Rodriguez-Crespo I, Gonzalez-Ros JM, Ferragut JA, Paul DA, Peterson DL, et al. Thermal stability of hepatitis B surface antigen S proteins. Biochim Biophys Acta. 1992; 1119(3): 225-31[DOI][PubMed]
  • 21. Carman WF, Korula J, Wallace L, MacPhee R, Mimms L, Decker R. Fulminant reactivation of hepatitis B due to envelope protein mutant that escaped detection by monoclonal HBsAg ELISA. Lancet. 1995; 345(8962): 1406-7[DOI][PubMed]
  • 22. Yamamoto K, Horikita M, Tsuda F, Itoh K, Akahane Y, Yotsumoto S, et al. Naturally occurring escape mutants of hepatitis B virus with various mutations in the S gene in carriers seropositive for antibody to hepatitis B surface antigen. J Virol. 1994; 68(4): 2671-6[PubMed]
  • 23. Lehninger AL, Nelson DL, Cox MM. Lehninger principles of biochemistry. 1993; : 111-33
  • 24. Rezaee R, Poorebrahim M, Najafi S, Sadeghi S, Pourdast A, Alavian SM, et al. Impacts of the G145R Mutation on the Structure and Immunogenic Activity of the Hepatitis B Surface Antigen: A Computational Analysis. Hepat Mon. 2016; 16(7)[DOI][PubMed]
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:



Create Citiation Alert
via Google Reader

Readers' Comments